Long-term Continuous 5-Fluorouracil Infusion in Patients with Advanced Head and Neck Cancer

By Sørensen Peter   Andersen Lisbeth J.   Hansen Olfred   Bastholt Lars  

Acta Oncologica, Vol. 38, Iss. 8, 1999-12 ,pp. : 1043-1045

Informa Healthcare

Access to resources Recommend Favorite

A phase II study using vinorelbine and continuous 5-fluorouracil in patients with advanced head and neck cancer

By Larsen Susanne   Serup-Hansen Eva   Andersen Lisbeth J.   Lindeløv Birgit   McCulloch Tine   Adimi Parvin   Bastholt Lars  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 374-377

Informa Healthcare

Access to resources Recommend Favorite

Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy

By                              

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1580-1586

Spandidos Publications

Access to resources Recommend Favorite

Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

By Katori Hideaki   Tsukuda Mamoru   Watai Kiichi  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 3, 2007-08 ,pp. : 399-406

Springer Publishing Company

Access to resources Recommend Favorite

Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil

By Sai Heitetsu   Mitsumori Michihide   Yamauchi Chikako   Araki Norio   Okumura Setsuko   Nagata Yasushi   Nishimura Yasumasa   Hiraoka Masahiro  

International Journal of Clinical Oncology, Vol. 9, Iss. 3, 2004-06 ,pp. : 149-153

Springer Publishing Company

Access to resources Recommend Favorite